Cassava Sciences Inc
NASDAQ: SAVA
$26.95
+$1.61 (+6.4%)
Closing Price on November 8, 2024
SAVA Stock Chart and Intraday Price
SAVA Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 7801 N CAPITAL OF TEXAS HIGHWAY, SUITE 260, AUSTIN, TX, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 971.45M USD |
| Shares Outstanding | 42,236,900 |
SAVA Articles
Meme stocks traded well-mixed at midday Thursday. The morning's most surprising turn came from a stock that missed estimates and gave lower guidance but still traded higher.
Published:
Meme stock winners far outnumbered losers on Tuesday, and one of those winners is posting another big gain in Wednesday's premarket.
Published:
On Tuesday, the biggest winner among meme stocks was Cassava Sciences, while Camber Energy took the biggest hit.
Published:
Retail investors may be revving up a short squeeze on a stock that was hammered on Monday.
Published:
U.S. retail investors now own 12 times more stock than do hedge funds, and Americans have a greater percentage of their money in savings and stock portfolios than at any time since 1950.
Published:
An FDA directive has hammered a coronavirus vaccine maker Friday morning as a new variant of the infection is discovered in South Africa.
Published:
Here's a look at why five favorite retail stocks were all trading up by double digits at noontime Friday.
Published:
A federal investigation into one company's research data has caused its stock to crater, while a rebuttal of a short seller's claims have lifted another.
Published:
EV stocks were losing some of their recent gains, and one biotech has announced a new federal investigation.
Published:
A company developing a treatment for Alzheimer's disease got a big boost Thursday when a journal in which the company published a report said it found no basis for allegations of data and image...
Published: